Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells
Luís M. A. Oliveira, Lisandro J. Falomir‐Lockhart, Michelle Botelho Caarls, et al.
Cell Death and Disease (2015) Vol. 6, Iss. 11, pp. e1994-e1994
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Autophagy in Parkinson's Disease
Xu Hou, Jens O. Watzlawik, Fabienne C. Fiesel, et al.
Journal of Molecular Biology (2020) Vol. 432, Iss. 8, pp. 2651-2672
Open Access | Times Cited: 280
Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies
Hugo Vicente Miranda, Éva M. Szegő, Luís M. A. Oliveira, et al.
Brain (2017) Vol. 140, Iss. 5, pp. 1399-1419
Open Access | Times Cited: 188
α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies
Iryna Prots, Janina Grosch, Razvan-Marius Brazdis, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 30, pp. 7813-7818
Open Access | Times Cited: 188
Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models
Era Taoufik, Georgia Kouroupi, Ourania Zygogianni, et al.
Open Biology (2018) Vol. 8, Iss. 9
Open Access | Times Cited: 164
Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells
Jenne Tran, Helena Targa Dias Anastacio, Cédric Bardy
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 143
Reverse engineering Lewy bodies: how far have we come and how far can we go?
Mohamed Bilal Fares, Somanath Jagannath, Hilal A. Lashuel
Nature reviews. Neuroscience (2021) Vol. 22, Iss. 2, pp. 111-131
Closed Access | Times Cited: 140
Loss of monomeric alpha-synuclein (synucleinopenia) and the origin of Parkinson's disease
Alberto J. Espay, Andrew Lees
Parkinsonism & Related Disorders (2024) Vol. 122, pp. 106077-106077
Open Access | Times Cited: 17
Alpha-synuclein induces the unfolded protein response in Parkinson’s disease SNCA triplication iPSC-derived neurons
Sabrina M. Heman-Ackah, Raquel Manzano, Jeroen J.M. Hoozemans, et al.
Human Molecular Genetics (2017) Vol. 26, Iss. 22, pp. 4441-4450
Open Access | Times Cited: 134
iPSC modeling of young-onset Parkinson’s disease reveals a molecular signature of disease and novel therapeutic candidates
Alex Laperle, Samuel Sances, Nur Yucer, et al.
Nature Medicine (2020) Vol. 26, Iss. 2, pp. 289-299
Closed Access | Times Cited: 114
Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models
Sarah Logan, Thiago Arzua, Scott G. Canfield, et al.
Comprehensive physiology (2019), pp. 565-611
Open Access | Times Cited: 106
Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages
Walther Haenseler, Federico Zambon, Heyne Lee, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 103
Cellular models of alpha‐synuclein toxicity and aggregation
Marion Delenclos, Jeremy D. Burgess, Agaristi Lamprokostopoulou, et al.
Journal of Neurochemistry (2019) Vol. 150, Iss. 5, pp. 566-576
Open Access | Times Cited: 98
Origin and pathophysiology of protein carbonylation, nitration and chlorination in age-related brain diseases and aging
Efstathios S. Gonos, Μαριάννα Καπετάνου, Jolanta Sereikaitė, et al.
Aging (2018) Vol. 10, Iss. 5, pp. 868-901
Open Access | Times Cited: 91
Role of Autophagy Pathway in Parkinson’s Disease and Related Genetic Neurological Disorders
Christos Themistokleous, Enrico Bagnoli, Ramaa Parulekar, et al.
Journal of Molecular Biology (2023) Vol. 435, Iss. 12, pp. 168144-168144
Open Access | Times Cited: 29
Transcriptomic profiling of Parkinson's disease brains reveals disease stage specific gene expression changes
Chiara Cappelletti, Sandra Pilar Henriksen, Hanneke Geut, et al.
Acta Neuropathologica (2023) Vol. 146, Iss. 2, pp. 227-244
Open Access | Times Cited: 28
EndophilinA-dependent coupling between activity-induced calcium influx and synaptic autophagy is disrupted by a Parkinson-risk mutation
Adekunle T. Bademosi, Marianna Decet, Sabine Kuenen, et al.
Neuron (2023) Vol. 111, Iss. 9, pp. 1402-1422.e13
Open Access | Times Cited: 25
Experimental models of Parkinson’s disease: Challenges and Opportunities
Roshan Lal, Aditi Singh, S. Watts, et al.
European Journal of Pharmacology (2024) Vol. 980, pp. 176819-176819
Closed Access | Times Cited: 10
Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer’s and Parkinson’s Disease
Antea Kršek, Lara Batičić
Future Pharmacology (2024) Vol. 4, Iss. 2, pp. 352-379
Open Access | Times Cited: 9
Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson's disease
Gerard W. O’Keeffe, Aideen M. Sullivan
Parkinsonism & Related Disorders (2018) Vol. 56, pp. 9-15
Open Access | Times Cited: 75
Up-regulation of SNCA gene expression: implications to synucleinopathies
Lidia Tagliafierro, Ornit Chiba‐Falek
Neurogenetics (2016) Vol. 17, Iss. 3, pp. 145-157
Open Access | Times Cited: 68
Cellular models as tools for the study of the role of alpha-synuclein in Parkinson's disease
Diana F. Lázaro, Maria Angeliki S. Pavlou, Tiago F. Outeiro
Experimental Neurology (2017) Vol. 298, pp. 162-171
Closed Access | Times Cited: 64
Nurr1: A vital participant in the TLR4-NF-κB signal pathway stimulated by α-synuclein in BV-2 cells
Qian-hang Shao, Wen-Fen Yan, Zhao Zhang, et al.
Neuropharmacology (2018) Vol. 144, pp. 388-399
Closed Access | Times Cited: 62
Midbrain organoids with anSNCAgene triplication model key features of synucleinopathy
Nguyen‐Vi Mohamed, Julien Sirois, Janani Ramamurthy, et al.
Brain Communications (2021) Vol. 3, Iss. 4
Open Access | Times Cited: 53
The Role of Alpha-Synuclein and Other Parkinson’s Genes in Neurodevelopmental and Neurodegenerative Disorders
C. Alejandra Morato Torres, Zinah Wassouf, Faria Zafar, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5724-5724
Open Access | Times Cited: 50
The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders
Ebenezeri Erasto Ngowi, Yizhen Wang, Lei Qian, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top